Healthcare entity
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention B.C. Man, the most common co-covered peer. Their average consequence score of 9 runs above the beat's 5.6 for that window. Each story carries 2 original sources on average, compared with 4.7 for the broader beat in this window.
Last mentioned: Feb 26, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention B.C. Man, the most common co-covered peer. Their average consequence score of 9 runs above the beat's 5.6 for that window. Each story carries 2 original sources on average, compared with 4.7 for the broader beat in this window. We currently track 1 Healthcare story that mention Gene-editing technology, all published on February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gene-editing technology. Shared-story counts are live from our verified record — not editorial picks.
Public Announcement
The success of the world-first procedure was made public by Canadian health authorities.
Cure Confirmation
Medical teams confirmed the patient's genetic markers had stabilized at healthy levels.
Treatment Administered
A single infusion of the gene-editing therapy was delivered to the patient in B.C.
Clinical Trial Enrollment
Patient enrolled in the world-first trial for in-vivo gene editing.
A British Columbia resident has become the first person in the world to be functionally cured of a rare genetic condition using a novel in-vivo gene-editing platform. This milestone marks a transition from managing chronic symptoms to permanent, one-time curative interventions for hereditary diseases.
Source: stcatharinesstandard.ca · chroniclejournal.com
Gene-editing technology is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
